Anticoagulation during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type II and renal impairment using heparin and the platelet glycoprotein IIb-IIIa antagonist tirofiban

Anesthesiology

Volumn 94, Issue 2, 2001, Pages 245-251

  Koster, Andreas ^a   Kukucka, Marian ^a   Bach, Friedhelm ^b   Meyer, Oliver ^c   Fischer, Thomas ^a   Mertzlufft, Fritz ^b   Loebe, Matthias ^a   Hetzer, Roland ^a   Kuppe, Hermann ^a  

^a DEUTSCHES HERZZENTRUM BERLIN   (Germany)

^b Clinic for Anesthesia and Intensive Care Medicine   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ABCIXIMAB; DANAPAROID; HEPARIN; LEPIRUDIN; RECOMBINANT HIRUDIN; TIROFIBAN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG INDICATION; DRUG SAFETY; FEMALE; HUMAN; KIDNEY FAILURE; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; THROMBOEMBOLISM;

EID: 0035141342     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200102000-00013     Document Type: Article

References (24)

1. Heparin-associated thrombocytopenia and thrombosis: Implications for perioperative management
2. Heparin-induced thrombocytopenia
3. Heparin-induced thrombocytopenia
4. Heparin-induced thrombocytopenia: Pathophysiology
5. Management of patients with heparin-induced thrombocytopenia (HIT): An overview of 230 patients treated with Orgaran (Org 10172)
6. A 14 year study of heparin-induced thrombocytopenia
7. A rapid and sensitive test for diagnosing heparin-induced thrombocytopenia
8. Heparin-induced thrombocytopenia in patients who undergo open heart surgery
9. Emergent cardiopulmonary bypass in five patients with heparin-induced thrombocytopenia type II employing recombinant hirudin
10. Recombinant hirudin as anticoagulant for cardiopulmonary bypass in patients with heparin-induced thrombocytopenia type: II. Importance of preoperative renal function
11. Heparin-induced thrombocytopenia type II: Perioperative management using danaparoid sodium in a coronary artery bypass patient with renal failure
12. Heparin-induced thrombocytopenia: Management of patients for open heart surgery. Case reports describing the use of iloprost
13. Fundamentals of coagulation and glycoprotein IIb/IIIa receptor inhibition
14. Tirofiban: A review of its use in acute coronary syndromes
15. In vitro efficiency of platelet glycoprotein IIb/IIIa antagonist in blocking platelet function in plasma of patients with heparin-induced thrombocytopenia
16. Heparin-induced thrombocytopenia: The role of platelet activation and therapeutic implications
17. Effect of glycoprotein IIb/IIIa antagonists on the HIT serum induced activation of platelets
18. Effect of SR121566A, a potent GP IIb-IIIa antagonist, on the HIT serum/heparin-induced platelet mediated activation of human endothelial cells
19. Adenosine diphosphate (ADP) and ADP receptor play a major role in platelet activation/aggregation induced by sera from heparin-induced thrombocytopenia patients
20. In vitro and in vivo studies on the metabolism of tirofiban
21. Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: An overview
22. Sera from patients with heparin-induced thrombocytopenia generate platelet derived microparticles with procoagulant activity: An explanation of the thrombotic complications of heparin-induced thrombocytopenia
23. Recombinant hirudin (lepirudin) provides safe and effective anticoagulation in patients with heparin-induced thrombocytopenia: A prospective study